• Skip to main content

Mobius Therapeutics

Dedicated to perioperative pharmaceuticals for ophthalmology

  • Home
  • Products
    • Product Lineup
    • Peri-Operative Resource Center
  • Place An Order
  • News
  • About Us
    • Company Profile
    • The Mobius Team
    • Terms of Use
    • Privacy Policy
    • Corporate Responsibility
  • Contact Us

Mobius Therapeutics Site Map

    • Mobius Therapeutics
    • Products – WMT-002 rev. 07/2022
      • Mobius Product Lineup – WMT-002 rev. 01/2018
      • Peri-Operative Ophthalmology – WMT-004 rev. 07/2022
        • DQSA Law – WMT-005 rev. 01/2018
        • USP Guidance – WMT-008 rev. 01/2018
        • USP 800 NIOSH Alert – WMT-009 rev. 01/2018
        • IJO Article – Hyaluronidase Clinical Trial – WMT-012 rev. 01/2018
    • How To Place An Order – WMT-014 rev. 07/2022
      • Mobius Shop – WMT-017 rev. 01/2018
    • News
      • Press Releases – WMT-018 rev. 01/2018
        • Leiters and Mobius Agreement for Mitosol – WMT-035 rev 02/2019
    • About Us – WMI-023 rev. 11/2019
      • Company Profile – WMT-022 rev. 01/2018
      • The Mobius Therapeutics Team – WMT-021 rev. 01/2018
        • Ed Timm – WMT-028 rev. 01/2018
        • Mark Wright – WMT-029 rev. 01/2018
      • Corporate Responsibility – WMI-026 Rev 05/2022
      • Terms of Use – WMI-027 Rev 11/2019
      • Privacy Policy – WMI-028 Rev 07/2022
    • Mobius Shopping Cart – WMT-026 rev. 01/2018
    • Checkout – WMT-027 rev. 01/2018

    © 2025 · Mobius Therapeutics